25 XP   0   0   10

Venus Remedies Limited
Buy, Hold or Sell?

Let's analyse Venus Remedies Limited together

PenkeI guess you are interested in Venus Remedies Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Venus Remedies Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Venus Remedies Limited

I send you an email if I find something interesting about Venus Remedies Limited.

Quick analysis of Venus Remedies Limited (30 sec.)










What can you expect buying and holding a share of Venus Remedies Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR344.39
Expected worth in 1 year
INR403.92
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
INR59.53
Return On Investment
17.9%

For what price can you sell your share?

Current Price per Share
INR333.50
Expected price per share
INR296.35 - INR368.70
How sure are you?
50%

1. Valuation of Venus Remedies Limited (5 min.)




Live pricePrice per Share (EOD)

INR333.50

Intrinsic Value Per Share

INR-192.52 - INR569.35

Total Value Per Share

INR151.86 - INR913.74

2. Growth of Venus Remedies Limited (5 min.)




Is Venus Remedies Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$55.2m$52.8m$2.3m4.3%

How much money is Venus Remedies Limited making?

Current yearPrevious yearGrowGrow %
Making money$3.1m$4.8m-$1.6m-53.3%
Net Profit Margin4.8%6.8%--

How much money comes from the company's main activities?

3. Financial Health of Venus Remedies Limited (5 min.)




What can you expect buying and holding a share of Venus Remedies Limited? (5 min.)

Welcome investor! Venus Remedies Limited's management wants to use your money to grow the business. In return you get a share of Venus Remedies Limited.

What can you expect buying and holding a share of Venus Remedies Limited?

First you should know what it really means to hold a share of Venus Remedies Limited. And how you can make/lose money.

Speculation

The Price per Share of Venus Remedies Limited is INR333.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Venus Remedies Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Venus Remedies Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR344.39. Based on the TTM, the Book Value Change Per Share is INR14.88 per quarter. Based on the YOY, the Book Value Change Per Share is INR30.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Venus Remedies Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.240.1%0.240.1%0.370.1%0.160.0%0.100.0%
Usd Book Value Change Per Share0.180.1%0.180.1%0.360.1%0.180.1%0.070.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.180.1%0.180.1%0.360.1%0.180.1%0.070.0%
Usd Price Per Share1.95-1.95-3.24-1.83-1.67-
Price to Earnings Ratio8.17-8.17-8.87-3.70-11.76-
Price-to-Total Gains Ratio10.92-10.92-9.00-3.99--1.07-
Price to Book Ratio0.47-0.47-0.82-0.49-0.43-
Price-to-Total Gains Ratio10.92-10.92-9.00-3.99--1.07-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.002
Number of shares249
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.180.18
Usd Total Gains Per Share0.180.18
Gains per Quarter (249 shares)44.4744.01
Gains per Year (249 shares)177.88176.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101781680176166
203563460352342
305345240528518
407127020704694
508898800880870
6010671058010561046
7012451236012321222
8014231414014081398
9016011592015841574
10017791770017601750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%6.04.00.060.0%13.04.00.076.5%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%5.05.00.050.0%12.05.00.070.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.017.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%5.05.00.050.0%12.05.00.070.6%

Fundamentals of Venus Remedies Limited

About Venus Remedies Limited

Venus Remedies Limited engages in the development and marketing of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizers, hormones, iron supplements, neurology, oncology, pain management, respiratory, skin care, wound management, stress reliever, urology, and vitamins/minerals/nutrients, as well as antimicrobial resistance products. It is also involved in the provision of anti-infective, anticoagulant, and a portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.

Fundamental data was last updated by Penke on 2024-04-04 07:24:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Venus Remedies Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Venus Remedies Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Venus Remedies Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 4.8% means that ₹0.05 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Venus Remedies Limited:

  • The MRQ is 4.8%. The company is making a profit. +1
  • The TTM is 4.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.8%TTM4.8%0.0%
TTM4.8%YOY6.8%-2.0%
TTM4.8%5Y2.2%+2.6%
5Y2.2%10Y1.8%+0.4%
1.1.2. Return on Assets

Shows how efficient Venus Remedies Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Venus Remedies Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.4% Return on Assets means that Venus Remedies Limited generated ₹0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Venus Remedies Limited:

  • The MRQ is 4.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.4%TTM4.4%0.0%
TTM4.4%YOY7.0%-2.6%
TTM4.4%5Y3.4%+1.0%
5Y3.4%10Y2.2%+1.2%
1.1.3. Return on Equity

Shows how efficient Venus Remedies Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Venus Remedies Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 5.8% Return on Equity means Venus Remedies Limited generated ₹0.06 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Venus Remedies Limited:

  • The MRQ is 5.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.8%TTM5.8%0.0%
TTM5.8%YOY9.2%-3.5%
TTM5.8%5Y3.8%+2.0%
5Y3.8%10Y2.7%+1.0%

1.2. Operating Efficiency of Venus Remedies Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Venus Remedies Limited is operating .

  • Measures how much profit Venus Remedies Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Venus Remedies Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 6.9% means the company generated ₹0.07  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Venus Remedies Limited:

  • The MRQ is 6.9%. The company is operating less efficient.
  • The TTM is 6.9%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.9%TTM6.9%0.0%
TTM6.9%YOY6.1%+0.8%
TTM6.9%5Y5.0%+1.9%
5Y5.0%10Y7.0%-2.0%
1.2.2. Operating Ratio

Measures how efficient Venus Remedies Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.95 means that the operating costs are ₹0.95 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Venus Remedies Limited:

  • The MRQ is 0.950. The company is less efficient in keeping operating costs low.
  • The TTM is 0.950. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.950TTM0.9500.000
TTM0.950YOY0.952-0.002
TTM0.9505Y0.969-0.020
5Y0.96910Y0.937+0.032

1.3. Liquidity of Venus Remedies Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Venus Remedies Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.91 means the company has ₹3.91 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Venus Remedies Limited:

  • The MRQ is 3.911. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.911. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.911TTM3.9110.000
TTM3.911YOY2.998+0.913
TTM3.9115Y2.322+1.589
5Y2.32210Y1.816+0.506
1.3.2. Quick Ratio

Measures if Venus Remedies Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Venus Remedies Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.85 means the company can pay off ₹2.85 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Venus Remedies Limited:

  • The MRQ is 2.847. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.847. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.847TTM2.8470.000
TTM2.847YOY1.294+1.552
TTM2.8475Y1.149+1.697
5Y1.14910Y0.831+0.318

1.4. Solvency of Venus Remedies Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Venus Remedies Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Venus Remedies Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.23 means that Venus Remedies Limited assets are financed with 23.4% credit (debt) and the remaining percentage (100% - 23.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Venus Remedies Limited:

  • The MRQ is 0.234. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.234. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.234TTM0.2340.000
TTM0.234YOY0.240-0.006
TTM0.2345Y0.359-0.125
5Y0.35910Y0.415-0.056
1.4.2. Debt to Equity Ratio

Measures if Venus Remedies Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Venus Remedies Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 30.6% means that company has ₹0.31 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Venus Remedies Limited:

  • The MRQ is 0.306. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.306. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.306TTM0.3060.000
TTM0.306YOY0.316-0.011
TTM0.3065Y0.637-0.332
5Y0.63710Y0.767-0.130

2. Market Valuation of Venus Remedies Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Venus Remedies Limited generates.

  • Above 15 is considered overpriced but always compare Venus Remedies Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 8.17 means the investor is paying ₹8.17 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Venus Remedies Limited:

  • The EOD is 16.778. Based on the earnings, the company is fair priced.
  • The MRQ is 8.173. Based on the earnings, the company is underpriced. +1
  • The TTM is 8.173. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD16.778MRQ8.173+8.605
MRQ8.173TTM8.1730.000
TTM8.173YOY8.872-0.699
TTM8.1735Y3.701+4.471
5Y3.70110Y11.758-8.057
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Venus Remedies Limited:

  • The EOD is 15.478. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 7.539. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 7.539. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD15.478MRQ7.539+7.938
MRQ7.539TTM7.5390.000
TTM7.539YOY13.238-5.699
TTM7.5395Y5.078+2.461
5Y5.07810Y46.458-41.380
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Venus Remedies Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.47 means the investor is paying ₹0.47 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Venus Remedies Limited:

  • The EOD is 0.968. Based on the equity, the company is cheap. +2
  • The MRQ is 0.472. Based on the equity, the company is cheap. +2
  • The TTM is 0.472. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.968MRQ0.472+0.497
MRQ0.472TTM0.4720.000
TTM0.472YOY0.820-0.349
TTM0.4725Y0.487-0.015
5Y0.48710Y0.434+0.053
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Venus Remedies Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--14.88314.8830%30.046-50%14.727+1%6.076+145%
Book Value Per Share--344.385344.3850%329.503+5%292.805+18%308.700+12%
Current Ratio--3.9113.9110%2.998+30%2.322+68%1.816+115%
Debt To Asset Ratio--0.2340.2340%0.240-3%0.359-35%0.415-44%
Debt To Equity Ratio--0.3060.3060%0.316-3%0.637-52%0.767-60%
Dividend Per Share----0%-0%-0%-0%
Eps--19.87719.8770%30.466-35%13.539+47%8.519+133%
Free Cash Flow Per Share--21.54721.5470%20.419+6%42.734-50%24.471-12%
Free Cash Flow To Equity Per Share--21.12121.1210%13.329+58%0.771+2638%-4.255+120%
Gross Profit Margin---2.015-2.0150%-0.196-90%0.999-302%-2.523+25%
Intrinsic Value_10Y_max--569.354--------
Intrinsic Value_10Y_min---192.521--------
Intrinsic Value_1Y_max--47.809--------
Intrinsic Value_1Y_min--13.575--------
Intrinsic Value_3Y_max--150.692--------
Intrinsic Value_3Y_min--12.562--------
Intrinsic Value_5Y_max--262.070--------
Intrinsic Value_5Y_min---19.377--------
Market Cap4457894500.000+51%2171469150.0002171469150.0000%3613100100.000-40%2038601170.000+7%1863226130.000+17%
Net Profit Margin--0.0480.0480%0.068-30%0.022+120%0.018+164%
Operating Margin--0.0690.0690%0.061+13%0.050+38%0.070-2%
Operating Ratio--0.9500.9500%0.9520%0.969-2%0.937+1%
Pb Ratio0.968+51%0.4720.4720%0.820-42%0.487-3%0.434+9%
Pe Ratio16.778+51%8.1738.1730%8.872-8%3.701+121%11.758-30%
Price Per Share333.500+51%162.450162.4500%270.300-40%152.510+7%139.390+17%
Price To Free Cash Flow Ratio15.478+51%7.5397.5390%13.238-43%5.078+48%46.458-84%
Price To Total Gains Ratio22.409+51%10.91510.9150%8.996+21%3.995+173%-1.069+110%
Quick Ratio--2.8472.8470%1.294+120%1.149+148%0.831+242%
Return On Assets--0.0440.0440%0.070-37%0.034+29%0.022+97%
Return On Equity--0.0580.0580%0.092-38%0.038+54%0.027+110%
Total Gains Per Share--14.88314.8830%30.046-50%14.727+1%6.076+145%
Usd Book Value--55240800.00055240800.0000%52853568.000+5%46967148.000+18%49516700.400+12%
Usd Book Value Change Per Share--0.1790.1790%0.361-50%0.177+1%0.073+145%
Usd Book Value Per Share--4.1334.1330%3.954+5%3.514+18%3.704+12%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.2390.2390%0.366-35%0.162+47%0.102+133%
Usd Free Cash Flow--3456240.0003456240.0000%3275232.000+6%6854736.000-50%3925219.200-12%
Usd Free Cash Flow Per Share--0.2590.2590%0.245+6%0.513-50%0.294-12%
Usd Free Cash Flow To Equity Per Share--0.2530.2530%0.160+58%0.009+2638%-0.051+120%
Usd Market Cap53494734.000+51%26057629.80026057629.8000%43357201.200-40%24463214.040+7%22358713.560+17%
Usd Price Per Share4.002+51%1.9491.9490%3.244-40%1.830+7%1.673+17%
Usd Profit--3187896.0003187896.0000%4886904.000-35%2171553.600+47%1666260.000+91%
Usd Revenue--66661200.00066661200.0000%71837964.000-7%56551946.400+18%54441270.000+22%
Usd Total Gains Per Share--0.1790.1790%0.361-50%0.177+1%0.073+145%
 EOD+4 -4MRQTTM+0 -0YOY+19 -155Y+27 -710Y+27 -7

3.2. Fundamental Score

Let's check the fundamental score of Venus Remedies Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.778
Price to Book Ratio (EOD)Between0-10.968
Net Profit Margin (MRQ)Greater than00.048
Operating Margin (MRQ)Greater than00.069
Quick Ratio (MRQ)Greater than12.847
Current Ratio (MRQ)Greater than13.911
Debt to Asset Ratio (MRQ)Less than10.234
Debt to Equity Ratio (MRQ)Less than10.306
Return on Equity (MRQ)Greater than0.150.058
Return on Assets (MRQ)Greater than0.050.044
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Venus Remedies Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose329.950
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets6,010,800
Total Liabilities1,407,400
Total Stockholder Equity4,603,400
 As reported
Total Liabilities 1,407,400
Total Stockholder Equity+ 4,603,400
Total Assets = 6,010,800

Assets

Total Assets6,010,800
Total Current Assets3,229,600
Long-term Assets2,781,200
Total Current Assets
Cash And Cash Equivalents 212,100
Short-term Investments 537,100
Net Receivables 1,064,100
Inventory 1,199,400
Other Current Assets 216,900
Total Current Assets  (as reported)3,229,600
Total Current Assets  (calculated)3,229,600
+/-0
Long-term Assets
Property Plant Equipment 1,628,200
Goodwill -61
Intangible Assets 792,461
Other Assets 332,400
Long-term Assets  (as reported)2,781,200
Long-term Assets  (calculated)2,753,000
+/- 28,200

Liabilities & Shareholders' Equity

Total Current Liabilities825,700
Long-term Liabilities581,700
Total Stockholder Equity4,603,400
Total Current Liabilities
Short-term Debt 36,100
Short Long Term Debt 36,100
Accounts payable 508,400
Other Current Liabilities 10,900
Total Current Liabilities  (as reported)825,700
Total Current Liabilities  (calculated)591,500
+/- 234,200
Long-term Liabilities
Long term Debt Total 386,800
Other Liabilities 194,900
Long-term Liabilities  (as reported)581,700
Long-term Liabilities  (calculated)581,700
+/-0
Total Stockholder Equity
Common Stock133,700
Retained Earnings 1,421,279
Accumulated Other Comprehensive Income 2,165,129
Capital Surplus 883,283
Total Stockholder Equity (as reported)4,603,400
Total Stockholder Equity (calculated)4,603,391
+/- 9
Other
Capital Stock133,700
Cash And Equivalents212,100
Cash and Short Term Investments 749,200
Common Stock Shares Outstanding 13,367
Current Deferred Revenue270,300
Liabilities and Stockholders Equity 6,010,800
Net Debt 210,800
Net Invested Capital 5,026,300
Net Tangible Assets 3,811,000
Net Working Capital 2,403,900
Property Plant and Equipment Gross 1,628,200
Short Long Term Debt Total 422,900



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
> Total Assets 
1,555,665
2,080,888
2,966,897
3,500,874
4,608,610
5,740,310
7,175,472
8,343,523
8,410,607
8,428,150
8,291,115
7,508,469
7,328,258
6,377,190
5,558,533
5,798,180
6,010,800
6,010,8005,798,1805,558,5336,377,1907,328,2587,508,4698,291,1158,428,1508,410,6078,343,5237,175,4725,740,3104,608,6103,500,8742,966,8972,080,8881,555,665
   > Total Current Assets 
384,540
641,136
1,030,227
1,186,641
1,520,700
1,696,338
2,255,778
2,721,159
2,674,646
2,770,693
2,606,208
2,637,681
2,654,337
2,879,517
2,315,952
2,780,398
3,229,600
3,229,6002,780,3982,315,9522,879,5172,654,3372,637,6812,606,2082,770,6932,674,6462,721,1592,255,7781,696,3381,520,7001,186,6411,030,227641,136384,540
       Cash And Cash Equivalents 
29,922
11,324
15,920
23,980
31,183
29,453
27,984
1,893
3,330
39,913
10,412
7,442
20,331
19,424
288,792
432,556
212,100
212,100432,556288,79219,42420,3317,44210,41239,9133,3301,89327,98429,45331,18323,98015,92011,32429,922
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
679,609
743,390
55,660
1,000
3,760
20,549
537,100
537,10020,5493,7601,00055,660743,390679,6090000000000
       Net Receivables 
0
0
0
0
0
0
0
656,164
636,740
897,970
754,868
894,731
930,510
627,254
611,383
726,794
1,064,100
1,064,100726,794611,383627,254930,510894,731754,868897,970636,740656,1640000000
       Inventory 
180,762
277,755
445,767
619,417
754,299
963,166
1,280,266
1,422,556
1,428,654
1,432,878
1,405,992
1,381,740
1,427,254
1,411,242
1,199,867
1,256,439
1,199,400
1,199,4001,256,4391,199,8671,411,2421,427,2541,381,7401,405,9921,432,8781,428,6541,422,5561,280,266963,166754,299619,417445,767277,755180,762
       Other Current Assets 
173,856
352,057
568,541
543,244
735,218
703,719
947,528
1,296,710
1,242,662
1,297,902
1,189,804
1,248,499
276,242
1,448,851
215,910
344,060
216,900
216,900344,060215,9101,448,851276,2421,248,4991,189,8041,297,9021,242,6621,296,710947,528703,719735,218543,244568,541352,057173,856
   > Long-term Assets 
1,171,125
1,439,752
1,936,670
2,314,232
3,087,910
4,043,972
4,919,694
5,622,364
5,735,961
5,657,457
5,684,907
4,870,788
4,673,921
3,497,673
3,242,581
3,017,782
2,781,200
2,781,2003,017,7823,242,5813,497,6734,673,9214,870,7885,684,9075,657,4575,735,9615,622,3644,919,6944,043,9723,087,9102,314,2321,936,6701,439,7521,171,125
       Property Plant Equipment 
1,117,187
1,402,234
1,913,279
2,303,561
3,085,879
2,002,042
2,452,397
2,810,305
2,828,466
2,825,431
2,794,146
2,733,360
2,651,494
2,087,338
1,908,232
1,786,280
1,628,200
1,628,2001,786,2801,908,2322,087,3382,651,4942,733,3602,794,1462,825,4312,828,4662,810,3052,452,3972,002,0423,085,8792,303,5611,913,2791,402,2341,117,187
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
18,850
0
0
0
0
000018,850000000000000
       Intangible Assets 
338
0
0
0
0
1,781,863
2,039,894
2,262,241
2,390,964
2,503,047
2,559,109
1,806,316
1,680,104
1,054,299
967,162
879,285
792,461
792,461879,285967,1621,054,2991,680,1041,806,3162,559,1092,503,0472,390,9642,262,2412,039,8941,781,8630000338
       Long-term Assets Other 
53,600
37,518
23,391
10,672
2,031
260,067
427,403
549,818
516,531
328,979
331,652
331,112
342,323
356,036
0
399,736
332,400
332,400399,7360356,036342,323331,112331,652328,979516,531549,818427,403260,0672,03110,67223,39137,51853,600
> Total Liabilities 
1,004,352
1,191,026
1,580,943
1,789,057
2,239,426
2,667,360
3,384,219
3,727,442
3,843,768
4,051,911
3,775,094
3,889,377
4,003,015
3,143,489
1,555,696
1,393,716
1,407,400
1,407,4001,393,7161,555,6963,143,4894,003,0153,889,3773,775,0944,051,9113,843,7683,727,4423,384,2192,667,3602,239,4261,789,0571,580,9431,191,0261,004,352
   > Total Current Liabilities 
133,145
192,035
205,065
219,491
278,410
1,532,246
1,912,460
2,109,918
1,965,188
1,931,365
1,980,283
2,304,658
2,636,229
2,185,266
974,451
927,385
825,700
825,700927,385974,4512,185,2662,636,2292,304,6581,980,2831,931,3651,965,1882,109,9181,912,4601,532,246278,410219,491205,065192,035133,145
       Short-term Debt 
0
0
0
0
0
0
1,421,395
1,486,590
1,521,695
1,441,683
1,498,003
1,696,048
1,819,709
1,483,965
44,874
41,661
36,100
36,10041,66144,8741,483,9651,819,7091,696,0481,498,0031,441,6831,521,6951,486,5901,421,395000000
       Short Long Term Debt 
0
0
0
0
0
0
0
2,886,430
30,811
208,448
1,498,003
1,696,048
1,819,709
1,483,965
43,050
41,660
36,100
36,10041,66043,0501,483,9651,819,7091,696,0481,498,003208,44830,8112,886,4300000000
       Accounts payable 
0
0
0
0
0
0
187,606
312,229
295,630
251,364
297,297
293,331
360,027
366,953
713,568
542,864
508,400
508,400542,864713,568366,953360,027293,331297,297251,364295,630312,229187,606000000
       Other Current Liabilities 
133,145
192,035
205,065
219,491
278,410
1,532,246
303,459
311,099
147,863
238,318
184,983
315,279
10,138
7,062
9,804
11,666
10,900
10,90011,6669,8047,06210,138315,279184,983238,318147,863311,099303,4591,532,246278,410219,491205,065192,035133,145
   > Long-term Liabilities 
871,206
998,991
1,375,878
1,569,566
1,961,016
1,135,114
1,471,759
1,617,524
1,878,580
2,120,546
1,794,811
1,584,719
1,366,786
958,223
581,245
466,331
581,700
581,700466,331581,245958,2231,366,7861,584,7191,794,8112,120,5461,878,5801,617,5241,471,7591,135,1141,961,0161,569,5661,375,878998,991871,206
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
1,618,189
1,374,388
1,160,180
720,533
468,310
386,790
386,800
386,800386,790468,310720,5331,160,1801,374,3881,618,1890000000000
       Other Liabilities 
0
0
0
0
0
0
0
217,683
192,532
210,087
177,019
210,330
206,606
237,690
112,935
79,539
194,900
194,90079,539112,935237,690206,606210,330177,019210,087192,532217,6830000000
> Total Stockholder Equity
551,313
889,863
1,385,954
1,711,817
2,369,184
3,072,950
3,791,254
4,616,074
4,566,843
4,376,239
4,516,023
3,619,092
3,325,243
3,233,701
4,002,837
4,404,464
4,603,400
4,603,4004,404,4644,002,8373,233,7013,325,2433,619,0924,516,0234,376,2394,566,8434,616,0743,791,2543,072,9502,369,1841,711,8171,385,954889,863551,313
   Common Stock
84,307
84,532
84,731
84,920
133,249
97,420
105,420
114,420
114,420
114,420
123,420
123,420
123,420
123,420
123,420
133,670
133,700
133,700133,670123,420123,420123,420123,420123,420114,420114,420114,420105,42097,420133,24984,92084,73184,53284,307
   Retained Earnings Total Equity00000000000000000
   Accumulated Other Comprehensive Income 
-83,730
-138,141
-191,608
-313,562
-495,959
-421,992
-537,951
0
-997,941
-1,230,725
-1,436,038
-1,664,046
-1,823,837
-2,027,193
2,372,842
2,227,266
2,165,129
2,165,1292,227,2662,372,842-2,027,193-1,823,837-1,664,046-1,436,038-1,230,725-997,9410-537,951-421,992-495,959-313,562-191,608-138,141-83,730
   Capital Surplus 
0
0
0
0
0
0
0
685,115
685,115
0
0
0
0
0
0
0
883,283
883,2830000000685,115685,1150000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
550,736
943,471
1,492,832
1,940,459
2,731,894
3,397,522
3,203,732
3,138,633
4,035,735
4,115,199
4,372,205
4,636,095
4,787,087
-2,371,915
756,008
883,283
883,292
883,292883,283756,008-2,371,9154,787,0874,636,0954,372,2054,115,1994,035,7353,138,6333,203,7323,397,5222,731,8941,940,4591,492,832943,471550,736



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue5,555,100
Cost of Revenue-3,309,900
Gross Profit2,245,2002,245,200
 
Operating Income (+$)
Gross Profit2,245,200
Operating Expense-1,966,200
Operating Income283,889279,000
 
Operating Expense (+$)
Research Development228,900
Selling General Administrative115,554
Selling And Marketing Expenses801,000
Operating Expense1,966,2001,145,454
 
Net Interest Income (+$)
Interest Income2,900
Interest Expense-2,900
Other Finance Cost-2,900
Net Interest Income-2,900
 
Pretax Income (+$)
Operating Income283,889
Net Interest Income-2,900
Other Non-Operating Income Expenses0
Income Before Tax (EBT)379,300188,474
EBIT - interestExpense = 379,300
379,258
268,558
Interest Expense2,900
Earnings Before Interest and Taxes (EBIT)382,200382,200
Earnings Before Interest and Taxes (EBITDA)705,200
 
After tax Income (+$)
Income Before Tax379,300
Tax Provision-113,600
Net Income From Continuing Ops265,700265,700
Net Income265,658
Net Income Applicable To Common Shares265,700
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,276,100
Total Other Income/Expenses Net95,4152,900
 

Technical Analysis of Venus Remedies Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Venus Remedies Limited. The general trend of Venus Remedies Limited is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Venus Remedies Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Venus Remedies Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 361.25 < 368.00 < 368.70.

The bearish price targets are: 302.00 > 300.00 > 296.35.

Tweet this
Venus Remedies Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Venus Remedies Limited. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Venus Remedies Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Venus Remedies Limited.

Venus Remedies Limited Daily Moving Average Convergence/Divergence (MACD) ChartVenus Remedies Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Venus Remedies Limited. The current adx is .

Venus Remedies Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Venus Remedies Limited.

Venus Remedies Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Venus Remedies Limited.

Venus Remedies Limited Daily Relative Strength Index (RSI) ChartVenus Remedies Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Venus Remedies Limited.

Venus Remedies Limited Daily Stochastic Oscillator ChartVenus Remedies Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Venus Remedies Limited.

Venus Remedies Limited Daily Commodity Channel Index (CCI) ChartVenus Remedies Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Venus Remedies Limited.

Venus Remedies Limited Daily Chande Momentum Oscillator (CMO) ChartVenus Remedies Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Venus Remedies Limited.

Venus Remedies Limited Daily Williams %R ChartVenus Remedies Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Venus Remedies Limited.

Venus Remedies Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Venus Remedies Limited.

Venus Remedies Limited Daily Average True Range (ATR) ChartVenus Remedies Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Venus Remedies Limited.

Venus Remedies Limited Daily On-Balance Volume (OBV) ChartVenus Remedies Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Venus Remedies Limited.

Venus Remedies Limited Daily Money Flow Index (MFI) ChartVenus Remedies Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Venus Remedies Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Venus Remedies Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Venus Remedies Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose329.950
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Venus Remedies Limited with someone you think should read this too:
  • Are you bullish or bearish on Venus Remedies Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Venus Remedies Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Venus Remedies Limited

I send you an email if I find something interesting about Venus Remedies Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Venus Remedies Limited.

Receive notifications about Venus Remedies Limited in your mailbox!